You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride
B. M. Prenner
To our knowledge, this is the first report of a neonatal withdrawal
syndrome associated with maternal usage of 600 mg daily of hydroxyzine
hydrochloride throughout pregnancy. This observation suggests that the use
of high doses of this agent in pregnancy should be avoided.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Central and autonomic system signs with in utero drug exposure
Bada et al. Arch. Dis. Child. Fetal Neonatal Ed. 2002;87:F106-112. ABSTRACT
| FULL TEXT
Neonatal Drug Withdrawal.
Committee on Drugs Pediatrics 1998;101:1079-1079. ABSTRACT
| FULL TEXT
